Related Articles
Impact of SGLT2 inhibitors on metabolic status in patients with psychiatric disorders undergoing treatment with second‑generation antipsychotics (Review)
Metabolic and cardiovascular benefits of GLP‑1 agonists, besides the hypoglycemic effect (Review)
Antipsychotic polypharmacy in adult patients diagnosed with schizophrenia: A retrospective study
The impact of exenatide (a GLP‑1 agonist) on markers of inflammation and oxidative stress in normal human astrocytes subjected to various glycemic conditions
Effects of glucagon‑like peptide‑1 receptor agonists on fracture healing in a rat osteoporotic model